Common Side Effects of Anticonvulsant Medications
Anticonvulsants share a core set of common side effects across all agents, with the most frequent being dizziness, somnolence, headache, and ataxia, though specific drugs have unique adverse effect profiles that should guide drug selection.
Universal Side Effects Across All Anticonvulsants
The most consistently reported adverse effects across anticonvulsant medications include 1:
- Dizziness (reported with gabapentin, lamotrigine, oxcarbazepine, zonisamide, levetiracetam, tiagabine)
- Somnolence/sedation (all agents)
- Headache (all agents)
- Ataxia (particularly lamotrigine, oxcarbazepine, tiagabine)
- Fatigue/asthenia (particularly zonisamide, levetiracetam)
These dose-dependent effects are reversible and represent the most common reason for treatment discontinuation 2.
Drug-Specific Side Effect Profiles
Gabapentin
- Most common: Somnolence, dizziness, fatigue 1
- Notable: Weight gain (higher occurrence versus placebo) 1
- Rare but reported: Involuntary movements (myoclonus, choreoathetosis), bowel/bladder incontinence 1
- Discontinuation rate: 3-11.5% due to adverse events 1
Lamotrigine
- Most common: Ataxia, dizziness, diplopia, somnolence, headache 1
- Critical concern: Rash in 10-17% of patients (versus 6-10% placebo), including Stevens-Johnson syndrome risk 1
- Discontinuation rate: 1-5% due to adverse events 1
- Important caveat: Adverse events more prevalent when combined with carbamazepine 1
Topiramate
- Most common: Emotional lability, difficulty concentrating, fatigue, memory deficits, weight loss 1
- Serious concerns: Metabolic acidosis, nephrolithiasis, angle-closure glaucoma 3
- Pediatric-specific: Hypohidrosis (reduced sweating) reported in children 1
Tiagabine
- Most common: Dizziness, tremor, abnormal thinking, nervousness, abdominal pain 1
- Serious concern: Nonconvulsive status epilepticus (absence stupor) 1
- Other: Emotional lability, psychosis 1
- Discontinuation rate: 8-20% 1
Oxcarbazepine
- Most common: Somnolence, dizziness, headache, ataxia, nausea, vomiting 1
- Critical concern: Hyponatremia (low sodium) 1
- Other: Diplopia, blurred vision, vertigo, tremor 1
- Discontinuation rate: Dose-dependent (3% at placebo, up to 67% at 2,400 mg/day) 1
Zonisamide
- Most common: Fatigue, dizziness, somnolence, anorexia, abnormal thinking 1
- Serious concerns: Renal calculi (kidney stones), rash, paranoia, depression 1
- Discontinuation rate: 10% 1
Levetiracetam
- Most common: Dizziness, somnolence, asthenia, headache, infection 1
- Psychiatric concerns: Behavioral problems, depression, psychosis 1
- Discontinuation rate: 7-13% (versus 5-8% placebo) 1
- Important note: No relationship between discontinuation rate and dose 1
Serious and Life-Threatening Adverse Effects
Beyond common side effects, clinicians must monitor for 2, 3, 4:
- Skin reactions: Hypersensitivity rashes, Stevens-Johnson syndrome (especially lamotrigine)
- Hepatotoxicity: Dose-related and hypersensitivity-mediated liver dysfunction
- Hematologic effects: Bone marrow suppression (rare but severe)
- Teratogenicity: Neural tube defects, particularly with valproate; risk largely unknown for newer agents 2
- Cognitive impairment: Of particular concern for working/studying patients 2
Critical Dosing Principles to Minimize Side Effects
The evidence consistently demonstrates that slower titration reduces adverse events across all anticonvulsants 1. For gabapentin, initiation at 900 mg/day in one day caused significantly more dizziness than 3-day titration 1. For levetiracetam, rapid initiation at 4,000 mg without titration increased somnolence and asthenia 1.
Key principle: Start low and titrate slowly to maximal tolerated dose, as efficacy and side effects both increase with dose 1.
Pediatric Considerations
In children, the side effect profile differs slightly 1:
- Gabapentin: Viral infection, fever, hostility, fatigue, weight gain
- Lamotrigine: Similar to adults but Stevens-Johnson syndrome reported
- Topiramate: Emotional lability, concentration difficulty, memory deficits, weight loss, hypohidrosis
- Oxcarbazepine: Similar to adults with 10% discontinuation rate
Drug Interactions and Metabolic Considerations
Conventional anticonvulsants have poor records regarding drug interactions due to hepatic enzyme interference 2. Newer agents like gabapentin and levetiracetam are renally excreted with lower interaction potential 2. Gabapentin showed no significant changes in concomitant AED levels 1.
Common Pitfalls to Avoid
- Rapid titration: Always use slower titration schedules to improve tolerability
- Ignoring drug combinations: Lamotrigine adverse events increase with carbamazepine; dose adjustments needed with valproate
- Missing hyponatremia: Monitor sodium levels with oxcarbazepine
- Overlooking psychiatric effects: Screen for behavioral changes, depression, and psychosis, particularly with levetiracetam
- Dismissing rash: Any rash with lamotrigine requires immediate evaluation for Stevens-Johnson syndrome